The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...

In a major breakthrough, researchers in the UK have discovered a potential root cause of inflammatory bowel disease (IBD), a ...

IBD and pregnancy require careful planning. Women with IBD can have healthy pregnancies by managing their condition with ...

Medications are often an important part of IBD treatment. IBD is an immune-mediated disease that causes persistent inflammation in the GI tract. Without treatment, it can continue to damage the GI ...

effective treatment, and improved quality of life. One of the hallmark symptoms of IBD is abdominal discomfort, often accompanied by cramping. In Crohn’s disease, this pain is typically located ...

Many with Crohn’s disease or ulcerative colitis sacrifice essential purchases like food and clothing for healthcare, survey ...

Major Cause of Inflammatory Bowel Disease Discovered June ... 2024 — A large-scale clinical trial of treatment strategies for Crohn's disease has shown that offering early advanced therapy ...

Women with inflammatory bowel disease who delivered a twin gestation ... The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second ...

The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...

Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Omvoh® ...

Biosimilar SB17 demonstrated clinical biosimilarity to reference ustekinumab after switching among patients with psoriasis ...